Foreign Filer Report • Aug 12, 2025
Foreign Filer Report
Open in ViewerOpens in native device viewer
_________ false
| ����� ��"� | 2 381 |
| EVOGENE LTD | |
| Corporation no: 512838723 | 14299 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C003 ( Public ) | Reported via MAGNA: | 12/08/2025 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2025-02-059675 | Time of broadcast: 10:52 10:52 |
The corporation scheduled the publication of the report to 12/08/2025 14:00Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on | Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases |
EVGN_Ehud_Gazit_TAU_PR_FINAL_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: -1 | Date of revision of form structure: 06/08/2024 |
| Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , Tel: 08-9311900 , Fax: 08-9466724 | |
| E-mail address: [email protected] Company site: www.evogene.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Deutsch Nitsan Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company: | |
| Address: Gad Feinstein 13 , Rehovot 7638517 Telephone: 08-9311900 Facsimile: 08-9466724 E-mail: [email protected] 1 | |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.